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Acanthamoeba polyphagamimivirus is a member of the giant
nucleocytoplasmic large DNA viruses, infecting various
Acanthamoeba spp. The genomes of giant viruses encode
components previously thought to be exclusive to cellular
life, such as proteins involved in nucleic acid and protein syn-
thesis. Recent work on enzymes involved in carbohydrate
biosynthesis and metabolism show that instead of utilizing
host cell resources, Mimivirus produces its own glycosylation
machinery. To obtain a more detailed view of glycosylation
in Mimivirus, we developed a periodate oxidation-based
method to selectively enrich Mimivirus surface glycopro-
teins. O-Glycosylation inMimivirus glycoproteins was identi-
ﬁed by permethylation and matrix-assisted laser desorption/
ionization-mass spectrometry analyses of beta-eliminated
glycans. We sequenced 26 previously undescribed O-glycans,
most of which contain glucose as their reducing end sacchar-
ide. These data will facilitate future studies on the functional
signiﬁcance of glycosylation in Mimivirus.
Keywords: beta-elimination / glycoprotein enrichment /
MALDI-mass spectrometry / methylation /
reducing-end analysis
Introduction
Acanthamoeba polyphaga mimivirus (Mimivirus) belongs
to the nucleocytoplasmic large DNA viruses (NCLDVs)
which includes Phycodnaviridae, Poxviridae, Asfarviridae,
Iridoviridae, Ascoviridae, Mimiviridae and Marseilleviridae
(Van Etten, Lane, et al. 2010). A recent addition to the new
family of giant viruses describes the largest viral genomes and
the genus name Pandoravirus was proposed (Philippe et al.
2013). Mimivirus was the ﬁrst member of the giant viruses to be
described, and gave its name to the family Mimiviridae.
NCLDVs contain internal lipid bilayer membranes and the some
Iridoviridae and Mimiviridae can be covered by long ﬁbers
protruding from the outer surface of their capsids (Yan et al.
2000; Xiao et al. 2005). NCLDVs display characteristics previ-
ously thought to be exclusive to cellular life. Their genes encode
proteins involved in DNA repair, RNA translation and protein
synthesis (Claverie and Abergel 2009). Members of the family
Phycodnaviridae infect algae and Mimiviridae, the largest
members of NCLDVs by particle and genome size, infect
amoebae found in both fresh and salt water environments
(Wilson et al. 2009; Thomas et al. 2011; Boughalmi et al. 2013).
The 1.2 Mb genome of Mimivirus has been sequenced and con-
tains 1018 genes with 979 open-reading frames annotated to
code for proteins (Raoult et al. 2004; Legendre et al. 2011).
Mimivirus encodes its own glycosylation machinery, a char-
acteristic that also has been reported for a member of the
Phycodnaviridae family, Paramecium bursaria chlorella virus.
The glycosylation machinery of P. bursaria chlorella virus has
been described to modify viral proteins independent of the host
ER or Golgi apparatus. Paramecium bursaria chlorella virus
encodes at least ﬁve glycosyltransferases as well as other
enzymes involved in carbohydrate metabolism (Van Etten,
Gurnon, et al. 2010). Its major capsid protein Vp54 is
N-glycosylated at four Asn and O-glycosylated at two Ser sites
as revealed by crystal structural analysis (Nandhagopal et al.
2002). The chemical structure of four highly branched and
unusual Vp54 N-glycoforms was reported recently (De Castro
et al. 2013). The ﬁrst indications of glycosylation in Mimivirus
came from its Gram-positive staining and the detection of
protein isoforms by 2D polyacrylamide gel electrophoresis
(PAGE) (Raoult et al. 2004). Furthermore, carbohydrate-
targeted gel-staining assays indicated the presence of various
glycoproteins in Mimivirus extracts (Raoult et al. 2004;
Renesto et al. 2006; Boyer et al. 2011). The Mimivirus ﬁbers
appear to be particularly rich in carbohydrate modiﬁcation, as
indicated by comparing the sugar compositions of intact versus
de-ﬁbered viral particles (Piacente et al. 2012). Analysis of the
Mimivirus genome predicted the presence of six glycosyltrans-
ferase genes in addition to enzymes required for the biosyn-
thesis of UDP-L-rhamnose and unusual amino-sugars such as
viosamine (4-amino-4,6-dideoxy-D-glucose, Vio) (Raoult et al.
2004; Parakkottil Chothi et al. 2010; Piacente et al. 2012). The
ﬁrst Mimivirus glycosyltransferase has been characterized
recently, and shown to be a bi-functional enzyme capable of
hydroxylating lysine and transferring glucose (Glc) to collagen
substrates (Luther et al. 2011).
Although the presence of glycosylation in Mimivirus is well
established, the extent and nature of Mimivirus glycosylation
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remains incompletely understood. Nothing is known about
N-linked and O-linked glycosylation in Mimivirus, and only a
few glycoproteins have been detected by an in-gel ﬂuorescence
staining approach using a no longer available commercial kit
(Renesto et al. 2006; Boyer et al. 2011). A more detailed under-
standing of Mimivirus surface glycosylation will foster future
studies on Mimivirus biology, such as those addressing the role
of glycosylation in virus–host interactions.
Results
With little known about glycosylation in Mimivirus, we aimed
to ﬁrst identify Mimivirus glycoproteins. Based on carbohy-
drate periodate oxidation we developed a method to selectively
enrich glycoproteins from the viral surface. We then released
and examined a diverse spectrum of linear and branched
Mimivirus O-glycans. In terms of total amount most glycans
contained Glc at their reducing terminus. Further, we addressed
the functional signiﬁcance of Mimivirus surface glycans for the
infection of the amoebal host.
Glycoprotein detection
For Mimivirus glycoprotein detection, we employed a biotinyla-
tion approach based on periodate oxidation of surface-exposed
glycans. Biotin was covalently coupled to oxidized glycans on
the virus particles using the aniline-catalyzed transimination re-
action with an amino-oxi-biotin probe (Dirksen et al. 2006). To
differentiate between speciﬁc protein binding to avidin via the
biotin probe and unspeciﬁc interactions of Mimivirus proteins
with the avidin column, we labeled peptides generated from peri-
odate oxidized, biotinylated column eluates versus untreated
samples using the 4-plex iTRAQ label reagents. The peptides
were subjected to LC-MS sequencing, analyzed and quantiﬁed
using Mascot and Scaffold Q+ software. The relative enrichment
of biotinylated proteins over unreacted proteins was statistically
validated using Student’s t-test and the calculated signiﬁcance
levels for enrichment was plotted against the log2 value for each
detected Mimivirus protein (Figure 1).
Protein enrichments above 1-fold were observed with signiﬁ-
cance levels of 0.5–1.0 for 40 proteins. High conﬁdence values
with signiﬁcance levels above 0.8, ranging from 1.1-fold up to
3.8-fold enrichments were observed for 28 biotinylated glyco-
proteins. The relatively broad range of fold enrichments may
reﬂect relative differences in glycoprotein abundance. It may
also be due to a differential degree of glycan oxidation with
periodate, depending on the number of saccharides containing
cis-hydroxyl versus trans-hydroxyl conﬁgurations (Honeyman
and Shaw 1959). Low enrichments with high signiﬁcance
values reﬂect the degree of nonspeciﬁc binding of Mimivirus
proteins to the avidin cartridge. More than half of these
enriched surface glycoproteins were also previously detected
by surface biotinylation analysis. The majority of these
proteins are annotated as uncharacterized proteins in UniProt
(Supplementary data Table I). Nevertheless, the crystal struc-
ture of the Mimivirus sulfhydryl oxidase R596 was solved pre-
viously (Hakim et al. 2012). We showed that this enzyme is
located at the viral surface (Shah et al. 2014). Here we could
enrich R596 after periodate oxidation/biotinylation, indicating
that R596 is a glycoprotein. The signiﬁcance level for enrich-
ment of 0.73 however, is only moderate (Supplementary data
Table I). Further, the virus surface location of collagen-like
protein L71 and the thioredoxin domain-containing protein
R362 were also described elsewhere (Shah et al. 2014). Both
proteins were susceptible to periodate oxidation/biotinylation.
Using the avidin cartridge puriﬁcation, they were enriched 1.4-
and 2.1-fold, with high statistical signiﬁcance (signiﬁcance
level of 0.95 and 1.00). Renesto et al. described the Mimivirus
Fig. 1. Enrichment of Mimivirus surface glycoproteins. Log2 enrichment of oxidized and biotinylated surface-glycoproteins relative to nonoxidized virus particles
via avidin cartridge puriﬁcation. A total of three independent particle oxidation/biotinylation reactions were performed and subjected to avidin cartridge puriﬁcation.
Eluted proteins were subjected to iTRAQ labeling, resulting in nine sample-blank iTRAQ pairs and subjected to mass-spectrometric peptide sequencing. The
signiﬁcance levels for enrichment of oxidized relative to nonoxidized samples were calculated using Student’s t-test function.
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capsid protein L425 as a glycoprotein, using a ﬂuorescent stain-
ing protocol for 2D-PAGE (Renesto et al. 2006). We could
identify this protein as located at the viral surface (Shah et al.
2014). Nevertheless, in this study, we were unable to conﬁrm
L425 as a glycoprotein. Using the periodate-oxidation/biotiny-
lation approach, L425 was only weakly enriched with poor stat-
istical signiﬁcance (signiﬁcance level of 0.59, Supplementary
data Table I). Using the same 2D-electrophoresis-based glyco-
protein staining approach, two further proteins, L829 and L135,
were described as glycoproteins of Mimivirus ﬁber structures
(Boyer et al. 2011). Here we could conﬁrm the surface-
glycoprotein status for L135 with a signiﬁcance level of 0.94
(Supplementary data Table I).
Monosaccharide analyses
The monosaccharide constituents in the viral protein extracts
were determined by high-performance anion-exchange chroma-
tography with pulsed amperometric detection (HPAEC-PAD)
after acid hydrolysis. In Mimivirus samples, three major mono-
saccharides were detected: rhamnose (Rha), glucosamine
(GlcN) and Glc, with a molar ratio of 1.9:2.6:1 (Figure 2). In
sample preparations omitting viral particles, the internal stand-
ard (Gal) was the only detectable saccharide, indicating that the
monosaccharide analyses were unaffected by contaminating
sugars.
Small amounts of fucose (Fuc) and Xyl could also be
detected. These ﬁndings are in good agreement with previous
compositional data using gas chromatography coupled mass
spectrometry (Piacente et al. 2012). In addition to Rha, GlcN
and Glc, Piacente et al. also detected Vio, methyl-Vio and
minor amounts of mannose (Man) and Gal. We were unable to
determine signiﬁcant amounts of Vio in the Mimivirus protein
extracts. Nevertheless, we consistently observed a peak eluting
close to the elution position of Vio in the chromatogram
(Figure 2). It is tempting to speculate that this peak corresponds
to methyl-Vio. With no methyl-Vio standards available
however, we could make no determination for this compound
in the current study. We also observed Gal and Man in
Mimivirus preparations. After repeated washing of the viral par-
ticles however, these saccharides remained below the detection
limit of the HPAEC-PAD. Thus, Gal and Man detected in our
virus samples probably originated from Acanthamoeba used
for culturing Mimivirus. Consequently, we used the absence of
Gal in the sample preparations as a quality control measure for
the purity of the viral particles and for quantitation of monosac-
charides, Gal was used as an internal standard.
Reductive β-elimination of Mimivirus O-glycans
and reducing-end analyses
The β-elimination reaction releases glycans O-linked to Ser or
Thr residues, whereas glycans attached to hydroxylysine are
stable to alkaline treatments (Hülsmeier et al. 2011; Luther
et al. 2011). Mimivirus O-glycans were radiolabelled by reduc-
tive β-elimination from protein extracts in the presence of
NaB3H4. The released glycans were subjected to HPAEC,
using a CarboPac PA200 column. The majority of the radiola-
bel interacted only weakly with the column and eluted at or
near the void volume. The reason for this chromatographic be-
havior is not clear. Possibly, hydrophobic glycan substitutions
are responsible for weak retention on this column and HPAEC
may be less suitable for those particular saccharides.
Nevertheless, a distinct peak eluting close to the elution pos-
ition of Glc4 at 12 min could be observed (Figure 3A).
For determination of the reducing-end saccharide, unfractio-
nated O-glycans, early-eluting and peak fractions at 12 min were
subjected to acid hydrolysis and to alditol analysis using a
CarboPac MA1 column. Glucitol was the major detected peak in
all fractions analyzed, indicating that Glc is a reducing end sac-
charide in the Mimivirus O-glycan preparation (Figure 3B).
Further, we analyzed partially permethylated and perdeutero-
methylated alditol acetates (PMAAs) prepared from Mimivirus
O-glycans by gas chromatography mass spectrometry (GC-MS).
We identiﬁed 2-, 6-substituted Glc at the reducing end together
with PMAAs derived from 4-substituted Glc, 2-, 6-substituted
Glc and terminal Glc (Figure 3C and D, Supplementary data
Figure 3), conﬁrming Glc as the main reducing end saccharide in
the unfractionated O-glycan pool.
O-glycan mass spectrometry
In order to obtain more detailed structural information about
Mimivirus O-glycans, the β-elimination reaction was per-
formed with NaBD4 as reducing agent. Released glycans were
permethylated and per-deuteromethylated, and fragmented by
matrix-assisted laser desorption/ionization-mass spectrometry
(MALDI-TOF/TOF-MS). The perdeuteromethylation leads to a
mass shift relative to the permethylated glycans in accordance
with the amount of deuterated methyl groups introduced
(Figure 4).
The major O-glycan signals can be referred to sequences
with Glc and Vio at the reducing terminus, which is in good
agreement with the results obtained from the reducing end ana-
lyses (Figure 3B–D). A total of 26 O-glycans were detected
and fragment-ion spectra of 15 permethylated and/or perdeuter-
omethylated oligosaccharides were recorded (Table I).
Fig. 2.Monosaccharide analysis of Mimivirus proteins. Protein extract was
subjected to acid hydrolysis and the monosaccharides were chromatographed
by HPAEC-PAD. The PAD response was measured in Coulomb (μC) and
plotted versus the RT. Gal was used as internal standard for quantitation of the
monosaccharide constituents. The arrow indicates the elution position of Vio.
Asterisk denotes an unidentiﬁed peak.
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All precursor ions, except for glycan O1.5, were detected in
the permethylated as well as in the perdeuteromethylated
samples. Furthermore, the use of methyl- and deuteromethyl
derivatization was beneﬁcial in detecting methyl- substitutions
on Mimivirus glycans, and was supportive in the oligosaccharide
sequence determinations. For example, diagnostic fragment ions
assigned from spectra of permethylated samples could be con-
ﬁrmed with the corresponding spectra acquired from perdeutero-
methylated glycans, providing additional conﬁdence in the
glycan sequence assignments. For six O-glycans, fragment ion
spectra were recorded from permethylated, as well as perdeutero-
methylated samples, allowing identical fragment ion assignments
from each sample (Figure 5). Ring fragment analysis was used in
saccharide linkage assignments (Supplementary data Table II
and Supplementary data Figure 1). Overall, the detected
Mimivirus glycans can be divided into six structural groups. All
groups, except glycans O1.4 to O1.7, are linear sequences elon-
gated by hexose polymers (Figure 6, Table I).
The Mimivirus glycans O1.4 to O1.7 showed branched confor-
mations with methyl modiﬁcations at terminal HexNAc residues
and hexose at the reducing end. The hexose residue corresponded
to 2-, 6-substituted glucitol as determined by the reducing end
analysis (Figure 3B–D). Ring fragment analysis in the spectrum
of glycan O1.6 (Figure 6A, Table I, Supplementary data Table II
and Supplementary data Figure 1) indicated the presence of ter-
minal pentose in 3- or 4-linkage to HexNAc. The linear glycans
can be grouped according to their reducing end residues being
di-methylated deoxy-hexose (Me2dHex), methylated deoxy-
hexosamine (MedHexN), di-methylated hexose (Me2Hex),
hexose (Hex) and methylated hexosamine (MeHexN, Table I).
Fig. 3.Mimivirus β-elimination products and reducing end analysis. (A) Mimivirus O-glycans were labeled with 3H during the reductive β-elimination reaction and
chromatographed by Dionex CarboPac PA200 HPAEC. Fractions were collected and the radioactivity was measured by liquid scintillation counting. Diamonds mark
the elution positions of a dextran partial hydrolysate calibrant, starting with a single Glc at the left to a Glc nonamer at the right. (B) Radiolabeled O-glycans were
acid hydrolyzed, mixed with authentic alditol standards, and chromatographed using a Dionex CarboPac MA1 column coupled to PAD. Alditols were prepared from
Fuc (Fuc-ol), GlcNAc (GlcNAc-ol), xylose (Xyl-ol), Rha (Rha-ol), and Glc (Glc-ol). Fractions were collected and the radioactivity was measured by liquid
scintillation counting. Diamonds indicate the elution positions of the alditol standards as indicated. The elution proﬁle obtained from the acid hydrolysis of
unfractionated O-glycans is shown. (C) Electron impact ionization mass spectrum of 1,3,4,5-tetramethyl-2,6-acetyl-glucitol derived from 2-, 6-substituted reducing
end Glc of unfractionated Mimivirus O-linked glycans, eluting at the RTof 0.733 relative to 2,3,4,6-trimethyl-1,5-acetyl-glucitol detected by GC–MS. (D) Electron
impact ionization mass spectrum of 1,3,4,5-tetra-deuteromethyl-2,6-acetyl-glucitol derived from 2-, 6-substituted reducing end Glc of unfractionated Mimivirus
O-linked glycans, eluting at the RTof 0.733 relative to 2,3,4,6-tri-deuteromethyl-1,5-acetyl-glucitol detected by GC-MS.
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Combining the results from the MALDI-TOF/TOF-MS fragment
ion spectra, the reducing end analysis, the monosaccharide ana-
lysis and published data on Mimivirus glycosylation (Piacente
et al. 2012), the monosaccharides Me2dHex, MedHexN, Me2Hex,
Hex and MeHexN probably correspond to di-methyl-Rha,
methyl-Vio, di-methyl-Glc, Glc and methyl-GlcN. The termin-
al pentose is predicted to be xylose and the oligohexoses to be
glucose polymers. Alpha- and beta-anomeric Glc extensions
might be present in the hexose-elongated Mimivirus O-glycans,
since an altered surface accessibility for biotinylation reagents
was observed upon amylase treatment of Mimivirus particles
(Supplementary data Figure 2). For the glycans O6.3 to O6.5,
the ring fragment analyses suggested glycosidic bonds in
4-linkage to the adjacent hexoses (Table I, Supplementary data
Table II and Supplementary data Figure 1). The 4-linkage might
also be present in glycans O2.4, O2.5, O3.3, O3.4, O4.4, O4.5
and the terminal residues in O5.4. Nevertheless, the fragment ion
spectra corresponding to these saccharides did not indicate ring
Fig. 4.MALDI-TOF-MS of β-eliminated Mimivirus O-glycans. Mimivirus O-glycans were β-eliminated, permethylated (A) or perdeuteromethylated (B) and
subjected to MALDI-TOF-MS. The molecular ions of major O-glycans are mass annotated and labeled with their corresponding glycan identiﬁcations (see Table I).
Symbols represent the proposed assignments. Circle, hexose; star, pentose; square, N-acetyl-hexosamine; triangle, deoxy-hexose; square with cross-line,
hexosamine; d, deoxy; Me, methyl; ol, reducing end.
Mimivirus glycosylation
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Table I.Mimivirus O-glycan sequences
Ident. Glycan composition M+Na+ deutero-
methylated
(measured)
M+Na+ deutero-
methylated
(calculated)
M+Na+
methylated
(measured)
M+Na+
methylated
(calculated)
MS2−spectra Proposed Sequence Red.-end*
O1.4 HexNAc2Hex2 1029.82 1029.8 984.58 984.52 CH3 HexNAc-Hex-[HexNAc]-Hex-ol Glc
O1.5 HexNac2Hex3 n.d. 1242.96 1188.66 1188.62
O1.6 HexNAcMeHexNAcHex2Pen 1192.89 1192.89 1144.64 1144.59 CH3/CD3 MeHexNAc-Hex-[Pen-(3/4)HexNAc]-Hex-ol Glc
O1.7 HexNAcMeHexNAcHex3Pen 1406.04 1406.05 1348.78 1348.69 CH3/CD3 [MeHexNAc-[Hex]-Hex]-[Pen-HexNAc]-Hex-ol Glc
O2.3 Hex2Me2dHex 695.51 695.52 n.d. 668.36 Me2Rha
O2.4 Hex3Me2dHex 908.69 908.67 n.d. 872.46 CD3 Hex-(4/6)Hex-Hex-Me2dHex-ol Me2Rha
O2.5 Hex4Me2dHex 1121.86 1121.83 n.d. 1076.56 CD3 Hex-(3/4)Hex-Hex-Hex-Me2dHex-ol Me2Rha
O3.2 HexMedHexN 501.43 501.44 n.d. 477.29 CD3 Hex-MeVio-ol MeVio
O3.3 Hex2MedHexN 714.63 714.6 681.33 681.39 CD3 Hex-(4/6)Hex-MeVio-ol MeVio
O3.4 Hex3MedHexN 927.8 927.75 885.45 885.49 CD3 Hex-(4/6)Hex-(4/6)Hex-MeVio-ol MeVio
O3.5 Hex4MedHexN 1140.97 1140.91 1089.57 1089.59 Hex-Hex-Hex-Hex-MeVio-ol MeVio
O3.6 Hex5MedHexN 1354.04 1354.07 1293.68 1293.69 Hex-Hex-Hex-Hex-Hex-MeVio-ol MeVio
O3.7 Hex6MedHexN 1567.2 1567.22 1497.79 1497.79 Hex-Hex-Hex-Hex-Hex-Hex-MeVio-ol MeVio
O3.8 Hex7MedHexN 1780.34 1780.38 1701.9 1701.89 Hex-Hex-Hex-Hex-Hex-Hex-Hex-MeVio-ol MeVio
O3.9 Hex8MedHexN 1993.54 1993.53 1906.03 1905.99 Hex-Hex-Hex-Hex-Hex-Hex-Hex-Hex-MeVio-ol MeVio
O3.10 Hex9MedHexN 2206.68 2206.69 2110.14 2110.09 Hex-Hex-Hex-Hex-Hex-Hex-Hex-Hex-Hex-MeVio-ol MeVio
O3.11 Hex10MedHexN 2419.75 2419.85 2314.24 2314.19 Hex-Hex-Hex-Hex-Hex-Hex-Hex-Hex-Hex-Hex-MeVio-ol MeVio
O3.12 Hex11MedHexN 2632.9 2633 2518.32 2518.29 Hex-Hex-Hex-Hex-Hex-Hex-Hex-Hex-Hex-Hex-Hex-MeVio-ol MeVio
O4.3 Hex2Me2Hex 728.55 728.56 698.37 698.37 Hex-Hex-Me2Hex-ol Me2Glc
O4.4 Hex3Me2Hex 941.73 941.71 n.d. 902.47 CD3 Hex-(3/4)Hex-(4/6)Hex-Me2Hex-ol Me2Glc
O4.5 Hex4Me2Hex 1154.87 1154.87 1106.6 1106.57 CD3 Hex-(3/4)Hex-Hex-(3/4)Hex-Me2Hex-ol Me2Glc
O5.3 Hex3 734.63 734.59 698.37 698.37 CH3/CD3 Hex-(4)Hex-Hex-ol Glc
O5.4 Hex4 947.81 947.75 902.48 902.47 CH3/CD3 Hex-(4/6)Hex-(4)Hex-Hex-ol Glc
O6.3 Hex2MeHexN 747.6 747.63 711.34 711.4 CH3 Hex-(4)Hex-MeHexN-ol MeGlcN
O6.4 Hex3MeHexN 960.76 960.78 915.47 915.5 CH3/CD3 Hex-(4)Hex-(4)Hex-MeHexN-ol MeGlcN
O6.5 Hex4MeHexN 1173.93 1173.94 1119.59 1119.6 CH3/CD3 Hex-(4)Hex-(4)Hex-(4)Hex-MeHexNol MeGlcN
*Reducing end assignment is based on the reducing-end analyses, monosaccharide analysis and published data on Mimivirus glycosylation (Piacente et al. 2012). O-glycan sequence assignments were
supported by fragment ion recordings and most confident sequence information were obtained from identical fragment ion assignments inferred from permethylated and perdeuteromethylated glycan samples
(MS2 spectra, CH3/CD3). Mass annotated MS2-spectra are shown in Supplementary data Figure 1 and the assigned fragment ions are listed in Supplementary data Table II. Individual glycans are named with
O1 to O6 referring to the glycan grouping applied, whereas the second digits correspond to the number of residues or the size of the O-glycan.
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fragmentation solely supportive for 4-linkages (Supplementary
data Table II and Supplementary data Figure 1). The detection of
PMAA derived from 4-substituted Glc of the unfractionated
O-glycans by GC-MS, however, conﬁrms 4-linked internal Glc
residues as a major structural motif in Mimivirus O-glycans
(Supplementary data Figure 3). Due to the lack of authentic
methylated monosaccharide standards, it was not possible to use
HPAEC-PAD to conﬁrm the MALDI-TOF-MS data suggesting
that mono- and di-methylated monosaccharides are at the redu-
cing ends of the O-linked oligosaccharide. Therefore, only the re-
ducing ends for glycans O1.4, O1.6, O1.7, O5.3 and O5.4 could
be directly conﬁrmed with the detection of glucitol by HPAEC-
PAD. For the O1.4, O1.6 and O1.7 glycans 2-, 6-substituted Glc
at the reducing end and at the internal branching residue was indi-
cated by GC-MS analyses of PMAAs derived from the unfractio-
nated glycan pool (Figure 3C and D, Supplementary data
Figure 3). Saccharides with Glc at the reducing end constitute the
most abundant O-glycans in Mimivirus (Table I, Figures 3B–D
and 4) and the branched O-glycans appear to account for a major
portion of these glycans, since mono-substituted Glc or other
reducing end saccharides could not be identiﬁed by GC-MS of
PMAAs derived from unfractionated Mimivirus O-glycans. The
monosaccharide analysis showed that N-acetylglucosamine
(GlcNAc) or GlcN is a major constituent in Mimivirus protein
extracts. Although it is the major monosaccharide in the analysis,
it does not necessarily imply that GlcNAc is a main constituent in
elongated Mimivirus O-glycosylation. GlcNAc may have other
functions in Mimivirus or be part of other classes of glycans,
apart from O-glycosylation on Ser or Thr.
Effect of amylase treatment on virus infectivity
Next, we addressed the functional signiﬁcance of Glc elonga-
tions of Mimivirus O-glycans on the infectivity toward the
Fig. 5. Schematic representation of selected Mimivirus O-glycans. For glycans
O1.6, O1.7, O5.3, O5.4, O6.4 and O6.5 precursor ion signals and fragment ion
spectra were recorded from permethylated and perdeuteromethylated samples,
allowing for high conﬁdence sequence assignments. Circle, hexose; star,
pentose; square, N-acetyl-hexosamine; square with cross line, hexosamine; Me,
methyl; ol, reducing end.
Fig. 6.MALDI-TOF/TOF-MS of permethylated O-glycans. Representative
fragment ion spectra of Mimivirus O-glycans. Glycans were β-eliminated from
Mimivirus proteins, permethylated and analyzed by MALDI-TOF/TOF-MS.
The inserted symbols represent the proposed assignments (A) O1.6,
perdeuteromethylated, (B) O3.3, perdeuteromethylated, (C) O5.3,
permethylated. Major fragment ions are labeled. Ion masses labeled with “*”
could not be assigned to the proposed O-glycan and might originate from
MALDI matrix interferences at low precursor ion intensities. Circle, hexose;
star, pentose; square, N-acetyl-hexosamine; square with cross line, hexosamine;
d, deoxy; Me, methyl; ol, reducing end.
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amoebal host. Acanthamoeba polyphaga was grown to loga-
rithmic phase in 96-well plates and infected with serial dilu-
tions of identical quantities of α-amylase treated and untreated
Mimivirus particles. Infected amoebae were assessed with
4′,6-diamidino-2-phenylindole, which results in a distinct ﬂuor-
escence staining of viral factories in the cytoplasm. The viral
titers necessary for infection were shown to be identical in
amylase digested and undigested Mimivirus samples, indicat-
ing that α-Glc elongations of Mimivirus surface glycans do not
play a role in the establishment of infection in the amoebal host
(Figure 7).
Discussion
The present study established that O-glycosylation is complex
and diverse in Mimivirus. This suggests that Mimivirus
O-glycosylation serves equally diverse and complex roles in
Mimivirus infection. Several NCLDVs families and Mimiviridae
are remarkable in the sense that instead of utilizing or modifying
the host glycosylation pathways, they rely on their own glycosy-
lation machinery (Parakkottil et al. 2010; Luther et al. 2011;
Piacente et al. 2012). Nevertheless, it remains unanswered why
Mimivirus glycosylates its surface proteins. Upon infection of
the host, Mimivirus expresses most of its protein coding
sequences, indicating that they are likely to be required to
perform key life cycle processes. Therefore, the expression of the
genome-encoded metabolic and biosynthetic pathways seem to
be of advantage for the virus to replicate within the host. The
Mimivirus genome repertoire appears to be nearly self-sufﬁcient
for replication, since it completes its entire lifecycle exclusively
in cytoplasmic viral factory assemblies, superseding the need for
initial DNA replication in the nucleus (Mutsaﬁ et al. 2010). In
this study we describe O-glycans with methyl and pentose sub-
stitutions to hexosamine residues. In Mimivirus, corresponding
transferase enzymes have not been identiﬁed. On the other hand,
terminally methylated and pentosylated N-glycans were also
described recently in Acanthamoeba spp. (Schiller et al. 2012). It
is tempting to speculate that Mimivirus may in part utilize host
enzymes for O-glycan biosynthesis. Methylated and pentose
substituted N-glycans were also identiﬁed in higher eukaryotic
organisms, such as in snails (Helix pomatia, Lymnaea stagnalis
and Biomphalaria glabrata) as well as in the parasitic worm
Schistosoma mansoni (van Kuik, van Halbeek et al. 1985; Van
Kuik, Sijbesma et al. 1986; Van Kuik, Sijbesma, Kamerling
et al. 1987; Geyer et al. 2005; Lehr et al. 2007). On the basis
of immunological cross-reactivity and common carbohydrate
epitopes found in these organisms, carbohydrate-mediated
molecular mimicry involved in host–parasite interactions has
been discussed as a possible biological role of such glycan
modiﬁcations.
The glycosylation in Mimivirus may have a role in facilitat-
ing capture by the amoebal host. Mimivirus glycans may be
required for host infection via initial binding to Acanthamoeba-
expressed receptors. We addressed this question by testing the
infectivity of Mimivirus after the removal of terminal Glc resi-
dues from the virus surface, and were unable to show a differ-
ence in infectivity after amylase treatment of virus particles.
Therefore, the Glc-elongated O-glycans described here might
have other biological functions. In Mimivirus, host-binding
epitopes might be represented by different glycoforms or
surface structures. Acanthamoeba express Man-binding lectins,
which mediate adhesion to the mammalian host during estab-
lishment of infection resulting in a cytopathic effect. Man-
binding lectin-mediated interactions are thought to play a role
in the amoeba-induced cytopathic effect by triggering the secre-
tion of contact-dependent cytotoxic proteases (Panjwani 2010).
Other functional roles for lectins in amoebae were described in
the human pathogen Entamoeba histolytica and the free living
social amoeba Dictyostelium discoideum. Entamoeba histoly-
tica expresses a trimeric Gal and N-acetylgalactosamine
(GalNAc)-binding lectin, which plays an essential role in cell
adherence and cytotoxicity. In this case, the Gal/GalNAc-lectin
also mediates evasion of the host complement system, possibly
via molecular mimicry of human CD59 (Petri et al. 2002). On
the other hand, Dictyostelium discoideum expresses two
GalNAc-binding lectins, discoidin I and discoidin II. The
precise function of discoidin I and discoidin II is unclear. They
may be involved in intercellular adhesion during formation of
the spores producing the multicellular fruiting body (Rosen
et al. 1973; Frazier et al. 1975).
Mimivirus surface glycosylation may also have a role after
uptake by the amoebal host, similar to strategies developed by
Mycobacterium tuberculosis for establishing infection in the host
cell. Mycobacterium tuberculosis is taken up by human macro-
phages via phagocytosis and establishes infection by interfering
with phagosomal maturation to lysosomes. It was shown that the
man-capped glycosyl-phosphatidylinositol lipoarabinomannan
blocks the phosphatidyl-inositol-3-phosphate dependent delivery
of cargo from the trans-Golgi-network to the phagosome, indu-
cing phagosome maturation arrest (Fratti et al. 2003). Mimivirus
was also reported to be phagocytosed by macrophages and virus
Fig. 7.Mimivirus titer after amylase digestion. Mimivirus particles were treated
with α-amylase and added in serial dilutions to A. polyphaga grown in 96-well
plates. After an incubation of 6 h at 28°C amoeba were stained with
4′,6-diamidino-2-phenylindole in PBS and the number of infected amoeba were
counted and plotted against the virus concentration in ng protein per ml. Empty
bars show the titer of untreated Mimivirus. Grey bars show the titer of
α-amylase digested Mimivirus. Error bars indicate the standard error of mean
and were calculated from three infections per virus titer.
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uptake was shown to be reduced upon treatment of the cells with
a phosphatidylinositol-3-kinase-speciﬁc inhibitor. Therefore, it
may be conceivable that Mimivirus glycans serve a similar func-
tion when taken up by phagocytosis.
The ﬁndings described in this study present a basis for
further investigations on the biological signiﬁcance of
Mimivirus glycosylation. Structural and topological informa-
tion on Mimivirus glycosylation will facilitate studies on the
mechanisms for establishing infection in the amoebal host.
Furthermore, the information provided in this study will be
beneﬁcial for further characterization of glycosyltransferases in
Mimivirus, aiding future investigations on the functional
signiﬁcance of Mimivirus glycosylation.
Materials and methods
Periodate oxidation and amino-oxy-biotinylation
of Mimivirus surface glycoproteins
For biotinylation of periodate oxidized surface glycoproteins,
we adapted a method described earlier based on amino-oxy-
biotinylation of sialo-glycoproteins on living cells (Dirksen
et al. 2006; Zeng et al. 2009). Mimivirus was grown on
Acanthamoeba polyphaga cultured in PYG medium as
described (Shah et al. 2014). After 2 days, viral particles were
collected from the amoeba lysates and puriﬁed by ﬁltration
through a 0.8 μm membrane, followed by centrifugation at
6000 × g. The Mimivirus pellet was washed at least six times
with PBS and resuspended to 450 μL with ammonium acetate-
buffered saline (100 mM ammonium acetate, 150 mM NaCl).
A 100 mM Na-meta-periodate solution was prepared freshly
with ammonium acetate-buffered saline and 50 μL was added
to the Mimivirus sample, resulting in a ﬁnal concentration of
10 mM Na-meta-periodate for the oxidation of glycans. Blank
samples were prepared by adding 50 μL ammonium acetate-
buffered saline only. The samples were incubated for 30 min at
room temperature, in the dark and an equal volume freshly pre-
pared 10 mM Na-meta-periodate in ammonium acetate-
buffered saline was added. Incubation was continued for further
30 min at room temperature, in the dark. The reaction was
quenched by adding 10 μL of 100 mM glycerol in ammonium
acetate-buffered saline each, followed by two washes with
ammonium acetate-buffered saline. The Periodate-oxidized
samples were resuspended in 1 mL 10 mM aniline and
amino-oxy-biotin (Biotium Inc.) was added to give a ﬁnal con-
centration of 0.1 mM. The samples were incubated for 90 min
at 4°C followed by two washes with 0.5 mL of ammonium
acetate-buffered saline and subjected to protein extraction.
Proteins were extracted by adding extraction buffer (0.5 M
Tris–HCl, pH 8.5, 0.2% CHAPS detergent, 5 mM TCEP, con-
taining 100 mg GuHCl per 150 μL buffer) and incubated at 60°
C for 1 h. Samples were cooled to room temperature and free
sulfhydryl groups were alkylated by adding 2 μmol methyl
methanethiosulfonate (MMTS). The extract was diluted 10-fold
with PBS, 0.1% CHAPS, containing proteinase inhibitors
(Calbiochem Proteinase Inhibitor Cocktail III, Merck
Millipore, USA) and subjected to an avidin cartridge puriﬁca-
tion (AB Sciex, USA). The sample was applied to the avidin
cartridge, equilibrated with PBS, 0.1% CHAPS. The cartridge
was washed with 500 μL PBS, 0.1% CHAPS, 1 mL 650 mM
NaCl in 20 mM phosphate buffer, pH 7.2, 0.1% CHAPS, 1 mL
PBS, 0.1% CHAPS, 1 mL 0.1% CHAPS in H2O successively
and biotinylated Mimivirus proteins were eluted with 800 μL
0.4% TFA, 0.1% CHAPS. The proteins were precipitated using
TCA. Nonoxidized blank samples were processed in parallel to
oxidized samples and digested with 0.2 μg Lys-C in 0.5 M
triethylammonium bicarbonate buffer, pH 8.5, 0.1% sodium
dodecyl sulfate, for 2 h at 37°C, followed by adding 5 μg
trypsin to give a ﬁnal volume of 30 μL. The samples were
digested at 37°C for 16 h. Oxidized versus blank samples were
differentially labeled with the 4-plex iTRAQ labeling kit and
subjected to cation exchange cartridge puriﬁcation (AB Sciex,
USA), following the manufacturer’s instructions. Samples were
desalted using ZipTip C18 tips (Millipore, USA) prior to
LC-MS on an Orbitrap XL mass spectrometer (ThermoFischer
Scientiﬁc Inc., USA), coupled to an Eksigent nano LC system
(Eksigent Technologies, USA).
Peptides were separated on a capillary tip column (75
µm × 80 mm) packed with reverse phase C18 material (AQ, 3
μm 200 Å, Bischoff GmbH, Germany). The column was equili-
brated with 95% solvent A (1% acetonitrile; 0.2% formic acid
in water) and 5% solvent B (80% acetonitrile; 0.2% formic acid
in water). Peptides were eluted with a ﬂow rate of 200 nL/min
using a 55 min linear gradient from 3 to 57% solvent B. The
analyses were performed in the data-dependent acquisition
mode. The three most intense precursor ions in the mass range
m/z 300–2000 were selected and one CID and a HCD spectrum
were acquired per precursor ion. Nominal collision energies of
35 and 42 V were applied for CID and HCD, respectively.
Dynamic exclusion was switched on, ensuring that up to 500m/z
ratios ±20 ppm values were excluded from MS/MS for 90 s. The
instrument was calibrated externally according to the manufac-
turer’s instructions.
The iTRAQ reporter ion channels from the HCD spectra
were concatenated to the CID fragment ion spectra in silico and
analyzed using the Mascot search algorithm (Matrix Science,
UK; Version: 2.4.1). Mascot was set up to search the Swissprot
database (downloaded 11.01.2011, 1,049,100 entries, contain-
ing decoy dataset and common contaminants) assuming the di-
gestion enzyme trypsin with maximal one missed cleavage.
Mascot was searched with a fragment ion mass tolerance of
0.60 Da and a parent ion tolerance of 10.0 ppm. MMTS alkyl-
ation of cysteine and AB Sciex iTRAQ multiplexed quantita-
tion chemistry of lysine and the N-terminus were speciﬁed in
Mascot as ﬁxed modiﬁcations. Oxidation of methionine and
AB Sciex iTRAQ multiplexed quantitation chemistry of tyro-
sine were speciﬁed in Mascot as variable modiﬁcations.
Scaffold (version Scaffold_3.4.9, Proteome Software Inc.,
USA) was used to validate MS/MS-based peptide and protein
identiﬁcations. Peptide identiﬁcations were accepted if they
could be established at >80.0% probability as speciﬁed by the
Peptide Prophet algorithm (Keller et al. 2002). Protein identiﬁ-
cations were accepted if they could be established at greater
than 99.0% probability and contained at least two identiﬁed
peptides. Protein probabilities were assigned by the Protein
Prophet algorithm (Nesvizhskii et al. 2003). Additionally,
peptide fragmentation spectra were manually inspected for
sequence identiﬁcation and iTRAQ reporter ion generation.
The Q+ multiplex calculation browser within Scaffold was
Mimivirus glycosylation
9
 at U
niversitaet Zuerich on M
ay 26, 2014
http://glycob.oxfordjournals.org/
D
ow
nloaded from
 
used for quantiﬁcation of the iTRAQ results, separately in pairs
of avidin-enriched sample and blank sample. Individual quanti-
tative samples were normalized within each acquisition run.
Intensities for each peptide identiﬁcation were normalized
within the assigned protein. The intensity-based, median-type
normalization and the average protein reference option with
normalization between samples were used. Nonunique peptides
were excluded from the calculations. Reporter ion peak heights
above 1% of the highest peak in a spectrum were used for quan-
titation. The quantitation results expressed as log2 of the fold
enrichment were exported from Scaffold and analyzed in
Microsoft-Excel 2010. To assess the signiﬁcance for a particu-
lar protein being enriched when biotinylated, we calculated the
mean values for enrichment above 0 using Student’s t-test. We
assumed that binding of nonbiotinylated and biotinylated pro-
teins to the avidin cartridge is normal distributed, with equal
variances for both groups. The t-values were calculated by div-
iding the mean by the standard error (standard deviation=2
ﬃﬃﬃ
n
p
)
and the degree of freedom values were determined (df = n − 1).
The T.DIST function in MS-Excel was used to determine the sig-
niﬁcance level values with the cumulative distribution function.
Monosaccharide analysis
Mimivirus protein extracts were pre-mixed with Gal as
internal standard and hydrolyzed with 2 M TFA for 4 h at
100°C. The hydrolyzate was dried, re-dissolved in water and
subjected to monosaccharide analysis using a CarboPac PA20
column attached to a HPAEC-PAD (Dionex, ThermoFischer,
USA). For quantitation, an external standard containing Rha,
GlcNAc, Gal and Glc was used. For analytical purposes, Vio,
Fuc, arabinose, GalNAc, xylose and Man were used as
standards.
Structural analysis of Mimivirus O-glycosides
Mimivirus O-glycans were liberated from protein extracts by
β-elimination in 0.1 M NaOH, 1 M NaBD4, for 72 h at 37°C
essentially as described previously (Hülsmeier et al. 2011).
Additionally, released glycans were puriﬁed using a paper-
disk-column. Paper disks were punched from Whatman 3MM
paper using an ofﬁce-type hole puncher. About 20 paper disks
were placed in a centrifugal ﬁlter device (Ultrafree-MC, 0.45
μm, Millipore, USA), washed with water and equilibrated with
butanol:ethanol:water (4:1:1, v:v:v). The β-elimination pro-
ducts were dissolved in 300 μL water, 300 μL ice-cold ethanol
and 1200 μL ice-cold butanol were added, and the sample was
loaded onto the paper disks by centrifugation at 100 × g. The
paper disk cartridge was washed with 2.5 mL of butanol:
ethanol:water (4:1:1, v:v:v) and the O-glycans were eluted with
2 mL water by centrifugation at 300 × g. The eluate was dried
and subjected to permethylation or perdeuteromethylation
using the NaOH method (Hülsmeier et al. 2011).
Permethylated glycans were dissolved in 10% acetonitrile and
applied to a SepPak C18 cartridge (Waters, USA), equilibrated
with 10% acetonitrile. The SepPak cartridge was washed with
4.5 mL of 15% acetonitrile and the glycans were eluted with
6 mL of 80% acetonitrile and analysed by MALDI-TOF/
TOF-MS (Hülsmeier et al. 2011). MS–MS spectra were
acquired with an ABSciex MALDI-TO/TOF 5800 mass spec-
trometer using the instrument parameters as described earlier
(Hülsmeier et al. 2010). Fragment ions were annotated aided by
the GlycoWorkbench software, version 2.1 (Ceroni et al. 2008).
O-glycan reducing end analysis
O-glycans were radiolabelled during the β-elimination reaction
by incubating Mimivirus protein extract in 0.1 mL of 0.1 M
NaOH, 1 M NaBD4, 5 mCi NaB
3H4 (15 Ci/mmol, Hartmann
Analytic GmbH, Germany), for 72 h at 37°C and processed as
described (Hülsmeier et al. 2011). Radiolabeled O-glycans
were chromatographed by HPAEC, using a CarboPac PA200
column (Dionex, ThermoFischer, USA). The column was equi-
librated in 0.1 M NaOH and 5 min after injecting the samples a
linear gradient from 0.1 M NaOH to 0.1 M NaOH, 0.15 M
sodium acetate, over 40 min at 0.4 mL/min was applied.
Fractions were collected every 15 s and 1/10 volume per frac-
tion was measured by scintillation counting (Packard Tri-Carb
2900TR liquid scintillation counter, PerkinElmer, USA). The
column ﬂow through up to 5 min retention time (RT), the eluate
between 5 and 7 min and the peak fractions between 41 and 45
min were combined, desalted by passage through a 4.5 mL
column of Dowex AG 50 × 8 (BioRad, USA), equilibrated and
eluted with water. The combined fractions and an aliquot taken
prior to CarboPac PA200 chromatography were subjected to
acid hydrolysis with 2 M TFA for 4 h at 100°C. The hydroly-
sates were dried and resuspended three times from 0.1 mL
methanol and mixed with alditol standards, prepared from Fuc,
GlcNAc, Xyl, Rha, Glc, 1 nmol each, and 5 nmol inositol. The
alditol mixture was chromatographed by HPAEC-PAD, using a
CarboPac MA1 column (Dionex, ThermoFischer, USA). The
column was equilibrated in 60 mM NaOH and 5 min after
injecting the samples a linear gradient from 60 mM NaOH to
660 mM NaOH, over 30 min at 0.4 mL/min was applied.
Fractions were collected directly into scintillation vials every
15 s, neutralized with acetic acid and measured by scintillation
counting.
For analyses by GC-MS, unfractionated permethylated and
perdeuteromethylated O-glycans were hydrolyzed in 0.5 mL of
4 M TFA for 4 h at 100°C. The samples were dried under a
stream of N2 and reduced over night with 0.5 mL 250 mM
NaBD4 in 1 M ammonia at 4°C. The samples were acidiﬁed
with 20% acetic acid in methanol and dried under a stream of
N2. Borate salts were removed by evaporation twice from 2 mL
of 1% acetic acid in methanol followed by three evaporations
from 2 mL methanol. Partially methylated alditols were dis-
solved in 0.8 mL pyridine/acetic anhydride (1:1, v:v) and incu-
bated under argon gas over night at 4°C. The samples were
dried under N2, re-dissolved in 2 mL dichloromethane and sub-
jected to 6–12 washes with 1 mL water each. The samples were
dried under N2, resuspended in 10–100 μL dichloromethane
and 1 μL was injected in a GCT Premier gas chromatograph
mass spectrometer, using electron impact ionization at 70 eV
(Waters Corp., USA). The chromatography was carried out
using a 0.25 mm × 30 m Rxi-5Sil MS w/10 m Integra-Guard
capillary column (Restek, USA) with an initial helium gas ﬂow
of 1 mL/min. The initial oven temperature of 80°C was held for
2 min, increased at 25°C/min until 130°C, followed by an in-
crease of 1.5°C/min until 200°C and 4°C/min until 290°C. The
ﬁnal temperature was held for 10.83 min, resulting in a total run
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time of 84 min. MS acquisition was performed by linear scan-
ning from m/z 40–840.
Mimivirus particle biotinylation and amylase digestion
Mimivirus particles were digested with α-amylase (500 U,
Bacillus sp., Sigma, Switzerland), in 1 mL PBS containing
Protease Inhibitor Cocktail Set 1 (Calbiochem, Millipore, USA)
for 90 min, rotating at room temperature. The particles were
washed twice with PBS and subjected to protein biotinylation
with sulpho-NHS-biotin (Pierce, USA) followed by protein puri-
ﬁcation with avidin cartridges as described above. A second
Mimivirus particle sample was biotinylated omitting amylase di-
gestion. The puriﬁed proteins were digested with trypsin,
desalted with ZipTip C18 tips and subjected to LC–MS.
Mimivirus titer measurement
Acanthamoeba polyphaga was grown to logarithmic phase in
ﬂat bottom 96-well plates. Identical amounts of Mimivirus par-
ticles (2.4 mg protein per mL PBS) were treated or untreated
with α-amylase as described above and diluted 1:10 with PBS
followed by 12 dilutions of 1:3 in the 96-well plate per infec-
tion. Amoebae were incubated for 6 h at 28°C to establish in-
fection. Then, the PYG medium was aspired and surface-
attached amoebae were washed with PBS, followed by ﬁxation
with 3% paraformaldehyde in PBS for 10 min. Amoebae
and viral factories were stained with 0.1 μg per ml 4′,6-
diamidino-2-phenylindole (Sigma, USA) in PBS for 15 min,
washed with PBS and counted using ﬂuorescence microscopy.
Infected cells were assessed as amoebae containing viral factor-
ies and plotted against the virus protein per well. The tissue
culture infectious dose at 50% per mL was calculated to be
1.022 × 103 and corresponds to 2.9 μg viral protein per mL.
Differences in infection with treated versus untreated virus par-
ticles were evaluated using the paired, two-tailed Student’s
t-test function with 95% conﬁdence intervals in GraphPad
Prism (Version 5.03).
Supplementary Data
Supplementary data for this article is available online at http://
glycob.oxfordjournals.org/.
Funding
This work was supported by the Swiss National Science
Foundation (grant number: 310030-129633) to T.H. and the
Stiftung für wissenschaftliche Forschung an der Universität
Zürich to A.J.H and T.H.
Acknowledgements
We thank Professor Michela Tonetti, University of Genova,
Italy, for providing the Vio standard. We a grateful to Drs Peter
Gehrig, Bernd Roschitzki, Jonas Grossmann, Endre Laczko
and Tshering Altherr at the Functional Genomics Center Zurich
for their support with the mass spectrometric analyses.
Abbreviations
Fuc, fucose; Gal, galactose; GalNAc, N-acetylgalactosamine;
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